This week on Pharma Research VIDEO Report: 1) Pharmaceutical companies have cut back on what they pay physicians to speak on their behalf, but the real attention getter will be the searchable database patients will be able to access with 2013 data on pharmacy spending of $10 or more with each U.S. doctor. 2) Sanofi breaks new industry ground by appointing the first Chief Patient Officer. 3) Charlotte Sibley returns to recommend three steps that pharmaceutical companies can take with their research departments to implement Big Data opportunities. 4) With the ACA’s 2014 enrollment period in the past, the first reports of its impact on the pharmaceutical industry are being released.
vitaTrackr: Let’s create data-enabled healthcare; IBM Watson battles cancer (PRVR–3/31/14)
This week on Pharma Research VIDEO Report:
1) Hats off to vitaTrackr, which has decided to take the lead by inviting key elements of the health care industry to join it in a collaboration to create the foundation for data-enabled health care. 2) IBM Watson is being assigned its most challenging task to date: helping to find medical cures for glioblastoma patients. 3) Pharma MR stalwart and proponent Charlotte Sibley speaks with Bob Lederer about how and why many pharmacos are missing the boat with Big Data. 4) The Ogilvy Awards handed out at the ARF ReThink Conference awarded 6 different health care-related organizations in a New York ceremony on March 25.
Google Flu Trends overstates U.S. influenza; CMS pushes Medicare Part D data release; PharmaGuy, John Mack, discusses pharmaco new MR technology usage; FDA finds new adverse event information source (PRVR–3/24 – 3/28/2014)
On this week’s Pharma Research VIDEO Report:
1) There has been successful social media-sourced tracking of contagious diseases, but the Google Flu Trends has overestimated the spread of influenza in the U.S. in 2011-2012 and 2012-2013, according to Time Magazine.
2) Center for Medicare & Medicaid Services is pushing ahead part of its proposed Part D changes that deal with release of data to reputable organizations doing legitimate work. It has health care insurance coverage implications.
3) Pharmaguy John Mack joins PRVR to discuss what he says happening with pharma market research.
4) The FDA’s search for adverse events has led it to support creation of software that allows it to access 100 million health insurance and health records.
Clinical caution with social media; Health problems versus coverage; MD new Rx adoption (PMRV–3/17/2014)
News on this week’s Pharma Research VIDEO Report:
1) The Tufts Center for the Study of Drug Development comments on the pharmaceutical industry’s cautious use of social media, explaining how it could be accelerated.
2) Prosper Insights & Analytics released its “Healthcare Coverage Vital Signs Matrix,” which studies the links between health problems of individuals and their actual healthcare coverage.
3) M/A/R/C Research EVP Randy Wahl discusses research’s tendency to overstate adoption of new drugs and what is being done about it.
4) The Center for Medicare & Medicare Services withdrew its proposal to revise Medicare Part D following protests in Washington by insurers, pharmacies, pharmacies, health providers and patients.
Med cost up 3-5%; pharmacos cut MD speaker fees; FDA eases adverse event reporting (PRVR–3/10/14)
This week’s Pharma Research VIDEO Report: 1) Costs for medications will rise 3-5% this year, after having dramatically slowed in recent years. 2) Pharmaceutical companies have radically reduced what they pay doctors to speak, well at least many of them have. 3) Generic drug manufacturers will fight FDA proposals that they be required to update their product labels when new information with concerns about branded equivalents appear. 4) FDA will make availability of adverse event reports much easier to find and collect. 5) Health care providers say the Affordable Care Act needs changes and revisions, but overwhelmingly see it as a positive step for U.S. healthcare. 6) The multimillion dollar injectable drug market for chronic conditions like diabetes may be in or a shakeup if Mir Imran’s “Robotic Pill” gets FDA approval. It is in preclinical testing. 7) Media technology company Sticky wins the PM360 award for most innovative company. 8) A press release last week declared the first broadcast medical marijuana commercial. The release pointed to Comcast as the broadcaster. Since the taping of this video, PRVR has learned that this release was part of a misleading campaign. We apologize for this mistaken report.
Here is the link to the commercial:
https://www.marijuanadoctors.com/content/page/view/91
RFL Communications, Inc. 